Fennec Pharmaceuticals (FENC) Change in Receivables (2023 - 2025)
Fennec Pharmaceuticals (FENC) posted Change in Receivables of $3.5 million for Q4 2025, up 0.52% on a QoQ basis from $3.4 million in Q3 2025, and up 1876.0% year-over-year from $175000.0 in Q4 2024.
Fennec Pharmaceuticals (FENC) Change in Receivables (2023 - 2025) Analysis & Trends
Fennec Pharmaceuticals' Change in Receivables history runs 3 years deep, the most recent figure standing at $3.5 million for Q4 2025.
- Quarterly Change in Receivables rose 1876.0% year-over-year to $3.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12.4 million (up 58.01% YoY) and the FY2025 annual result came in at $12.4 million, up 58.01% from the prior year.
- Change in Receivables was $3.5 million for Q4 2025 at Fennec Pharmaceuticals, up from $3.4 million in the prior quarter.
- Across five years, Change in Receivables topped out at $5.3 million in Q1 2025 and bottomed at $138000.0 in Q1 2023.
- A 3-year average of $2.3 million and a median of $2.1 million in 2023 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2024 — Change in Receivables slumped 95.92% — and 2025, when it soared 1876.0%.
- Fennec Pharmaceuticals' Change in Receivables stood at $4.3 million in 2023, then slumped by 95.92% to $175000.0 in 2024, then surged by 1876.0% to $3.5 million in 2025.
- Business Quant data shows FENC's Change in Receivables at $3.5 million in Q4 2025, $3.4 million in Q3 2025, and $265000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 75.30 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Fennec Pharmaceuticals | 287.77 Mn | 250.98 Mn | 12.01 Mn | 3.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.46 Mn |
| Dec 31, 2025 | 3.46 Mn |
| Sep 30, 2025 | 3.44 Mn |
| Sep 30, 2025 | 3.44 Mn |
| Jun 30, 2025 | 265,000.00 |
| Jun 30, 2025 | 265,000.00 |
| Mar 31, 2025 | 5.28 Mn |
| Mar 31, 2025 | 5.28 Mn |
| Dec 31, 2024 | 175,000.00 |
| Dec 31, 2024 | 175,000.00 |
| Sep 30, 2024 | 4.20 Mn |
| Sep 30, 2024 | 4.20 Mn |
| Jun 30, 2024 | 2.04 Mn |
| Jun 30, 2024 | 2.04 Mn |
| Mar 31, 2024 | 1.46 Mn |
| Mar 31, 2024 | 1.46 Mn |
| Dec 31, 2023 | 4.29 Mn |
| Dec 31, 2023 | 4.29 Mn |
| Sep 30, 2023 | 2.08 Mn |
| Sep 30, 2023 | 2.08 Mn |